S19L (p.Ser19Leu) variant of KRT4 (Keratin, type II cytoskeletal 4)

S19L (p.Ser19Leu) in KRT4 (Keratin, type II cytoskeletal 4) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.67 / 1. The record also includes population frequency data and structural context.

S19L (p.Ser19Leu) variant details